Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Olopatadine Eye Drops and Allergy Skin Testing
This study has been completed.
Study NCT00775658 Information provided by Vanderbilt University
First Received on October 17, 2008. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Allergic Rhinitis
Allergic Conjunctivitis
Additional conditions recognized in this trial
Conjunctivitis
Conjunctivitis, Allergic
Rhinitis
More general conditions related to this trial
Conjunctival Diseases
Eye Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Nose Diseases
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
olopatadine 0.2% opthalmic solution
Additional drug interventions recognized in this trial
Olopatadine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Allergic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Histamine H1 Antagonists, Non-Sedating
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Vanderbilt University
Back to top of Main Content
